Cite

HARVARD Citation

    Neumiller, J. et al. (2022). Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors. Touch reviews in endocrinology. p. . [Online]. 
  
Back to record